CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- PMID: 25752441
- DOI: 10.1016/j.juro.2015.02.2941
CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
Abstract
Purpose: CD8(+) TILs at different tumor sites have diverse clinical attributes, which might result from distinct tumor microenvironments that promote differentiation into distinct subsets. However, only a few markers have been identified that can define CD8(+) T-cell subsets. CD103 is a marker of tissue resident memory CD8(+) T cells. In this retrospective study we investigated the cellular source and clinical significance of CD103 expression in urothelial cell carcinoma of bladder tissues in situ.
Materials and methods: Immunohistochemistry and immunofluorescence were used to identify the cellular source of CD103 in bladder urothelial cell carcinoma tissues. Kaplan-Meier analysis and Cox proportional hazards regression models were applied to estimate overall and recurrence-free survival in 302 patients with bladder urothelial cell carcinoma.
Results: CD8(+) T cells but not natural killer cells accounted for most CD103 expressing cells in bladder urothelial cell carcinoma tissues. Notably CD103(+) cells were predominantly located in intratumor regions rather than in associated stroma (p < 0.0001). The density of intratumor CD103(+) TILs was inversely associated with tumor size (p < 0.0001) and could represent a favorable prognostic predictor of overall and recurrence-free survival (p = 0.002 and 0.011, respectively). Moreover, intratumor CD103(+) TILs were positively associated with the expression of cognate ligand E-cadherin in intratumor regions of bladder urothelial cell carcinoma tissues (p = 0.008).
Conclusions: Our findings suggest that CD8(+) T cells might have a significant role in tumor immunity by expressing CD103 in intratumor regions of bladder urothelial cell carcinoma tissues. Intratumor CD103(+) TILs could potentially serve as a prognostic marker in patients with bladder urothelial cell carcinoma.
Keywords: CD8; antigens; carcinoma; lymphocytes; prognosis; tumor infiltrating; urinary bladder.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.Clin Cancer Res. 2014 Jan 15;20(2):434-44. doi: 10.1158/1078-0432.CCR-13-1877. Epub 2013 Nov 4. Clin Cancer Res. 2014. PMID: 24190978
-
Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.Urol Oncol. 2014 Aug;32(6):791-7. doi: 10.1016/j.urolonc.2014.02.007. Epub 2014 Apr 29. Urol Oncol. 2014. PMID: 24794251
-
Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.Oncotarget. 2017 Feb 21;8(8):13762-13769. doi: 10.18632/oncotarget.14632. Oncotarget. 2017. PMID: 28099920 Free PMC article.
-
The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin.Front Immunol. 2018 Aug 15;9:1904. doi: 10.3389/fimmu.2018.01904. eCollection 2018. Front Immunol. 2018. PMID: 30158938 Free PMC article. Review.
-
Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis.Sci Rep. 2019 Mar 7;9(1):3808. doi: 10.1038/s41598-019-40527-4. Sci Rep. 2019. PMID: 30846807 Free PMC article.
Cited by
-
Tissue-resident lymphocytes: weaponized sentinels at barrier surfaces.F1000Res. 2020 Jul 9;9:F1000 Faculty Rev-691. doi: 10.12688/f1000research.25234.1. eCollection 2020. F1000Res. 2020. PMID: 32695313 Free PMC article. Review.
-
Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer.Br J Cancer. 2023 May;128(10):1828-1837. doi: 10.1038/s41416-023-02202-4. Epub 2023 Mar 3. Br J Cancer. 2023. PMID: 36869093 Free PMC article.
-
A new therapeutic target: the CD69-Myl9 system in immune responses.Semin Immunopathol. 2019 May;41(3):349-358. doi: 10.1007/s00281-019-00734-7. Epub 2019 Apr 5. Semin Immunopathol. 2019. PMID: 30953160 Review.
-
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy.Cancers (Basel). 2021 Oct 14;13(20):5142. doi: 10.3390/cancers13205142. Cancers (Basel). 2021. PMID: 34680292 Free PMC article.
-
Induction of resident memory T cells enhances the efficacy of cancer vaccine.Nat Commun. 2017 May 24;8:15221. doi: 10.1038/ncomms15221. Nat Commun. 2017. PMID: 28537262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials